Vivaldi Coelho Rogerio
SEC Form 4 insider trading activity
Vivaldi Coelho Rogerio has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including CRNX, VTRS, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Vivaldi Coelho Rogerio is listed as Director at Crinetics Pharmaceuticals, Inc. Inside the rolling window, Vivaldi Coelho Rogerio reported no open-market purchases and 2 open-market sales totaling $301K in CRNX. The largest disclosed transaction in the window is a sale of 5,000 CRNX shares on Mar 12, 2026, worth $181K.
Companies traded
Other insiders at CRNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$301K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Vivaldi Coelho Rogerio made?
Vivaldi Coelho Rogerio has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including CRNX, VTRS since 2026.
Which companies does Vivaldi Coelho Rogerio trade?
Vivaldi Coelho Rogerio has filed SEC Form 4 disclosures for 2 companies, including CRNX, VTRS.
When was Vivaldi Coelho Rogerio's most recent SEC Form 4 filing?
Vivaldi Coelho Rogerio's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Vivaldi Coelho Rogerio's total buy and sell value in the current window?
Inside the rolling retention window, Vivaldi Coelho Rogerio bought $0 and sold $301K based on SEC Form 4 filings.
What was Vivaldi Coelho Rogerio's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,000 CRNX shares on 2026-03-12, worth $181K, per SEC Form 4 filings.